You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ag-120

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Acute Myeloid Leukemia Trial in New Haven (AG-120, Nivolumab)

Withdrawn
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • New Haven, Connecticut
    Yale Cancer Center
Jan 6, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • AG-120
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma Trial in Worldwide (AG-120, Placebo)

Completed
Has Results
  • Advanced Cholangiocarcinoma
  • Metastatic Cholangiocarcinoma
  • AG-120
  • Placebo
  • Scottsdale, Arizona
  • +48 more
Dec 20, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • AG-120
  • +2 more
  • Duarte, California
  • +72 more
Aug 18, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (AG-120, Placebo for AG-120, AG-221)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • AG-120
  • +3 more
  • Adelaide, Australia
  • +181 more
Aug 31, 2021